140 related articles for article (PubMed ID: 15320781)
1. Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal.
Lee KN; Jackson KW; Christiansen VJ; Chung KH; McKee PA
Curr Med Chem Cardiovasc Hematol Agents; 2004 Oct; 2(4):303-10. PubMed ID: 15320781
[TBL] [Abstract][Full Text] [Related]
2. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.
Lee KN; Jackson KW; Christiansen VJ; Chung KH; McKee PA
Blood; 2004 May; 103(10):3783-8. PubMed ID: 14751930
[TBL] [Abstract][Full Text] [Related]
3. Natural heterogeneity of α2-antiplasmin: functional and clinical consequences.
Abdul S; Leebeek FW; Rijken DC; Uitte de Willige S
Blood; 2016 Feb; 127(5):538-45. PubMed ID: 26626994
[TBL] [Abstract][Full Text] [Related]
4. Characterization of wild-type and mutant alpha2-antiplasmins: fibrinolysis enhancement by reactive site mutant.
Lee KN; Tae WC; Jackson KW; Kwon SH; McKee PA
Blood; 1999 Jul; 94(1):164-71. PubMed ID: 10381509
[TBL] [Abstract][Full Text] [Related]
5. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.
Lee KN; Lee SC; Jackson KW; Tae WC; Schwartzott DG; McKee PA
Thromb Haemost; 1998 Oct; 80(4):637-44. PubMed ID: 9798984
[TBL] [Abstract][Full Text] [Related]
6. The level of circulating fibroblast activation protein correlates with incorporation of alpha-2-antiplasmin into the fibrin clot.
Uitte de Willige S; Malfliet JJCM; Abdul S; Leebeek FWG; Rijken DC
Thromb Res; 2018 Jun; 166():19-21. PubMed ID: 29649768
[TBL] [Abstract][Full Text] [Related]
7. Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.
Mosesson MW; Siebenlist KR; Hernandez I; Lee KN; Christiansen VJ; McKee PA
J Thromb Haemost; 2008 Sep; 6(9):1565-70. PubMed ID: 18564219
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin.
Abdul S; Peeters M; Brouwers E; Malfliet JJMC; Leebeek FWG; Declerck PJ; Rijken DC; Uitte de Willige S
PLoS One; 2018; 13(5):e0196911. PubMed ID: 29723259
[TBL] [Abstract][Full Text] [Related]
9. Addition of a sequence from alpha2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis.
Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
BMC Biotechnol; 2009 Mar; 9():15. PubMed ID: 19257897
[TBL] [Abstract][Full Text] [Related]
10. Why alpha-antiplasmin must be converted to a derivative form for optimal function.
Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
J Thromb Haemost; 2007 Oct; 5(10):2095-104. PubMed ID: 17883704
[TBL] [Abstract][Full Text] [Related]
11. Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin.
Singh S; Houng AK; Reed GL
Blood; 2019 Sep; 134(12):970-978. PubMed ID: 31395599
[TBL] [Abstract][Full Text] [Related]
12. Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis.
Uitte de Willige S; Malfliet JJ; Janssen HL; Leebeek FW; Rijken DC
J Thromb Haemost; 2013 Nov; 11(11):2029-36. PubMed ID: 24034420
[TBL] [Abstract][Full Text] [Related]
13. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein.
Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
Blood; 2006 Feb; 107(4):1397-404. PubMed ID: 16223769
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.
Lee KN; Jackson KW; Christiansen VJ; Dolence EK; McKee PA
J Thromb Haemost; 2011 May; 9(5):987-96. PubMed ID: 21251197
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Fibrinolysis by Coagulation Factor XIII.
Rijken DC; Uitte de Willige S
Biomed Res Int; 2017; 2017():1209676. PubMed ID: 28761875
[TBL] [Abstract][Full Text] [Related]
16. The alpha-2-antiplasmin Arg407Lys polymorphism is associated with abdominal aortic aneurysm.
Bridge KI; Macrae F; Bailey MA; Johnson A; Philippou H; Scott DJ; Ariens RA
Thromb Res; 2014 Sep; 134(3):723-8. PubMed ID: 25065555
[TBL] [Abstract][Full Text] [Related]
17. The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity.
Christiansen VJ; Jackson KW; Lee KN; McKee PA
Blood; 2007 Jun; 109(12):5286-92. PubMed ID: 17317851
[TBL] [Abstract][Full Text] [Related]
18. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
19. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
[TBL] [Abstract][Full Text] [Related]
20. On the localization of the cleavage site in human alpha-2-antiplasmin, involved in the generation of the non-plasminogen binding form.
Abdul S; Dekkers DHW; Ariëns RAS; Leebeek FWG; Rijken DC; Uitte de Willige S
J Thromb Haemost; 2020 May; 18(5):1162-1170. PubMed ID: 32034861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
